METTL3 and nonpapillary renal cell carcinoma: For example, researchers have stressed that lncRNA-XIST can be modified by METTL3 and RBM15/15B to promote the oncogenicity of ccRCC through the miR-302c/SDC1 axis (Patil et al., 2016; Zhang et al., 2017).